Introduction:
Both blood pressure and heart rate (HR) are important factors that constitute hemodynamic status.
Hypothesis:
We aimed to determine whether HR was independently associated with all-cause mortality and whether HR modified the association between systolic blood pressure (SBP) and all-cause mortality.
Methods:
We included adults aged ≥20 years from the 1999-2018 National Health and Nutrition Examination Surveys without cardiovascular disease, chronic kidney disease, chronic obstructive pulmonary disease, cancer, asthma, or beta blocker use. Resting HR was categorized into 10 beats-per-min increments, and SBP in 10-20 mmHg increments as shown in Table 1. Our primary outcome was all-cause mortality, determined using linkage to the National Death Index through 2019. We used multivariable Cox regression, stratified by HTN status and adjusted for the survey design.
Results:
Among 27,369 participants, 5984 (22%) had diagnosed HTN. A HR ≥80 was associated with at least a 30% increase in mortality risk, regardless of HTN status (Table 1). Among normotensive participants, a HR ≥80 was associated with higher mortality risk compared to HR <80 at all SBPs except for SBP ≥180 (Table 1). While there was significant interaction between continuous HR and SBP on all-cause mortality (p=0.02), there was no evidence of significant effect modification within individual SBP categories.
Conclusions:
A HR ≥80 was independently associated with increased all-cause mortality risk, regardless of HTN diagnosis. HR may be a surrogate for cardiorespiratory fitness. Further studies understanding the joint associations between SBP and HR are needed in both normotensive and hypertensive individuals.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.